Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CCCC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
CCCC stock price ended at $1.38 on Friday, after rising0%
The C4 Therapeutics Inc stock price increased by 0% on the last trading day (16 May 2025), rising from 1.39 to 1.38. Throughout the last trading session, the stock experienced a fluctuation of 4.81% , ranging from a day low of $1.35 to a day high of 1.415. The price has declined in 5 of the last 10 days, resulting in a total change of -20.69% during this period. On the last day, trading volume increase by 653.32K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.28M shares were traded, amounting to approximately 1.76M.
CCCC Technical Signals
CCCC(C4 Therapeutics Inc Corp) has 5 buy signals and 4 sell signals now. The current trend is downtrend starting from 2025-05-02. The total price change during this trend is -22.99%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of CCCC over the last 5 trading days is 1.25M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
CCCC Moving Average Analysis
C4 Therapeutics Inc's overall moving average trend leans more bearish as of Saturday, May 17, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.8280366666666668, and $2.0056666666666665. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.2532966666666665, and $1.0756666666666665. A break-down below any of these levels will issue sell signals.
CCCC Short Selling Analysis
The short sale ratio of C4 Therapeutics Inc(CCCC) as of 12 May 2025 is 15.98%, dropping from last trading day. With decreasing price from 1.47 to 1.58. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
4
Buy
5
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
10.397
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-144.666
Bullish
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.0262
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
11.903
Bullish
Williams %R (14 days)
WILLR_14 < -80
-96.774
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-0.29
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0626
Bearish
Closing price
close < fibonacci_S1
1.34
Bearish
Moving Average
10-day SMA crosses below 20-day SMA
--
Bearish
CCCC Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to C4 Therapeutics Inc(CCCC), our algorithm predicts CCCC's 1-month price at $1.66, with an 13.22%upwardshift. Using a similarity score up to 93.30%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for C4 Therapeutics Inc (CCCC.O) stock, as of Sunday, May 11, 2025 , forecasts a 13.22% change over the next month, based on its high correlation with OKE.N stock patterns. The similarity between their price movements over the analyzed periods is 93.3%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
CCCC
No Data
OKE
Up: 13.22%Similarity: 93.3%
Name
Similarity
Up/Down
OKE.N
93.30%
+13.22%
HNRG.O
92.98%
-2.63%
TRDA.O
92.91%
-3.46%
CBSH.O
92.90%
+3.91%
NRIM.O
92.81%
+6.07%
EXR.N
92.80%
-3.19%
SXI.N
92.71%
-3.45%
TMHC.N
92.68%
-1.97%
OMCL.O
92.64%
+31.40%
LUNG.O
92.55%
-0.14%
CCCC Seasonality Analysis
Based on CCCC's historical stock price data across all years, the probability of a positive return in May is40.00%, suggesting it maynotbe an ideal month to invest in CCCC. In contrast,Julyoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying C4 Therapeutics Inc (CCCC.O) stock in July has the highest probability of a positive return (100.00%), while March has the lowest probability (20.00%).
Performance Seasonality
The chart shows C4 Therapeutics Inc. (CCCC)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy C4 Therapeutics Inc (CCCC.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CCCC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying C4 Therapeutics Inc (CCCC.O) stock in a year?
The radar chart shows that buying C4 Therapeutics Inc (CCCC.O) stock in July has the highest probability of a positive return (100.00%), while March has the lowest probability (20.00%).
How has C4 Therapeutics Inc. (CCCC)'s stock price performed over the past three years?
CCCC's stock price fell by -11.44% in 2023,decreased by -44.79% in 2024, and went down by 62.3% in 2025.
Bearish technical signals of CCCC include: MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1, 10-day SMA crosses below 20-day SMA.
Is CCCC a buy based on overall technical signals summary?
CCCC has 5 buy signals and 4 sell signals now. Overall the technical rating for CCCC is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of CCCC.
What is the trend of C4 Therapeutics Inc (CCCC)'s moving average?
C4 Therapeutics Inc's overall moving average trend leans more bearish as of May 17 2025, with 4 negative signals and 0 positive signal.
What is price prediction for CCCC stock next month?
The price prediction chart for C4 Therapeutics Inc (CCCC.O) stock, as of May 11 2025, forecasts a 13.22% change over the next month, based on its high correlation with OKE stock patterns. The similarity between their price movements over the analyzed periods is 93.3%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for CCCC Stock?
The price prediction for CCCC stock in 2025 is expected to range between **$1.70 and $1.98**, driven by positive earnings, strong revenue growth, and upcoming clinical trial data.
What is price prediction 2030 for CCCC Stock?
The price prediction for CCCC stock by 2030 is **$10.00**, driven by potential successful clinical trial outcomes and commercialization of its pipeline. The stock could reach this level if cemsidomide and CFT1946 trials are successful, leading to significant revenue growth. However, if trials fail, the price could drop to **$0.50** due to the high-risk nature of biotech investments.